-
S26 - Scientific symposium sponsored by Novo Nordisk - Beyond Metabolic Control: Incretin Mimetics as Gamechangers in Cardiometabolic Inflammation and CV Risk
Done
-
S19 - Scientific symposium sponsored by Eli Lilly - Tirzepatide and the Cardiologist: A New Chapter in Cardiometabolic Risk Management
Done
-
S16 - Scientific symposium sponsored by MSD - Next-Gen Therapies in Cardiology: from Sotatercept to the Future of Lipid Management
Done
-
S10 - Scientific symposium sponsored by Alnylam - A new chapter in ATTR-CM: what comes next in clinical practice?
Done
-
S7 - Scientific symposium sponsored by AstraZeneca:Belgian Initiatives in Cardiovascular Care to improve the Journey of Patients with Heart Failure, Hypertension, and Cardiac Amyloidosis
Done
-
S22 - Scientific symposium sponsored by Bayer: Beyonttra: A new chapter in ATTR-CM management
Done
-
S29 - BWGNICI - Imaging in inflammatory myopericardial syndrome: update from the 2025 Guidelines
Done
-
S2 - Radiation
Done
-
LunchDone
-
S5 - Nursing - 2 - Inside the Rhythm: Devices, Leads, and Daily Living
Done
Prof. Dr. Antoine Bondue is Head of the Cardiology Department at HUB Erasme Hospital in Brussels, President of the Belgian Cardiac League, and President of the Belgian Council of Cardiovascular Genomics.
He is a member of the European Society of Cardiology (ESC) and a member of the European Council of Cardiovascular Genomics.
Professor Bondue specializes in cardiomyopathies, cardiac amyloidosis, inherited cardiac conditions, and neurodegenerative diseases.
Prof. Dr. Dominique Vandijck is a full professor of health economics at Ghent University and a guest professor at several other universities and colleges. Driven by his academic work, teaching and research, his focus lies on the future of healthcare, with particular emphasis on prevention, quality of care and efficiency. He also is a frequently asked keynote speaker and a regular contributor to the media on health policy/economic–related topics.
I am a full-time cardiologist at Cliniques universitaires St Luc, Brussels and Professor at the Catholic University of Louvain.
My clinical interests are Heart Failure and Heart Transplantation. With a research focus on heart failure with preserved ejection fraction.
Genetic Testing in HCM: From Diagnosis to Family Care
Prof. Dr. Tomas Robyns is a genetic cardiologist with expertise in hereditary arrhythmias and cardiomyopathies.
He is the head of the Centre for hereditary heart disease at the University hospitals Leuven; and president elect of the Belgian Council on Cardiogenomics.
His research focuses on the genotype phenotype relation of inherited cardiomyopathies and arrhythmia syndromes.
Six Pillars for a structured HCM Clinic
Prof. dr. Pieter Martens is cardiologist at ZOL Genk and is specialized in heart failure. In ZOL Genk he focusses on the invasive hemodynamic evaluation of heart failure, advanced heart failure and he leads the HCM clinic. He has a PhD in heart failure research and trained as advanced heart failure fellow at the Cleveland Clinic in Cleveland Ohio. He is author of >175 international peer reviewed papers including several in the New England Journal of Medicine. He has a ZAP-mandate at the Uhasselt as co-director of the Limburg Clinical Research Center. He is involved in the clinical trial unit of ZOL Genk and has a Master of Clinical trials from Oxford University.
